Total offers pharma processing and packaging solutions

Published: 21-Apr-2010
Manufacturing

Interphex Hub will stage series of free seminars with top industry speakers

Total Processing & Packaging 2010 takes place at the NEC, Birmingham, UK, from 25 – 27 May. The exhibition will feature for the first time a Robotics & Industrial Vision Pavilion that will showcase the latest technology solutions that enable businesses to increase productivity while also delivering efficiency savings.

Further highlights will be a series of dedicated free-to-attend seminars in both the Packaging Innovation and Interphex hubs.

Top pharmaceutical companies and specialist equipment suppliers have been confirmed as speakers for the Interphex Hub seminars. Leading names taking part in the seminar programme, sponsored by Bürkert Fluid Control Systems and chaired by Mike Warren, formerly of Niro Pharma, include GlaxoSmithKline, R5 Pharmaceuticals, Atacama Labs, Upperton, Oystar Manesty, Cognex, Hapa and Pharma Tech.

Taking place over the three days of the show, topics will include anticounterfeiting and mass serialisation, Track & Trace technologies, 2D data matrix codes, new technologies for formulation development and GMP manufacture, and a new system for the online monitoring of tablet coating thickness.

‘As a strong Reed Exhibitions brand known around the world, Interphex offers the ideal platform for companies to demonstrate their latest solutions to a wide variety of packaging and production challenges,’ said Ian Crawford, Group Exhibition Director. ‘The seminar programme is an excellent focal point for the Hub and promises to deliver some very interesting presentations and stimulating debates.’
See more

You may also like

Manufacturing

Optima Group offers innovative pharma ideas

Read more
Total Processing & Packaging exhibition Stand no: 5181

Trending Articles

  1. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications
  2. Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
  3. Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
  4. CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates amid DRC outbreak With no licensed vaccines available and more than 900 suspected cases already recorded, CEPI is urgently advancing mRNA, rVSV and viral vector candidates from Moderna, IAVI and Oxford/SII toward clinical trials
  5. FDA Form 483 flags falsified records and live bird infestation at Dabur India OTC plant A FDA inspection report issued in January 2026 has revealed widespread CGMP failures at Dabur India's Dadra and Nagar Haveli facility, including manipulated microbiology data, fraudulent equipment logs and unsanitary storage conditions

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Manufacturing

Optima Group offers innovative pharma ideas

<b>Total Processing & Packaging exhibition<br> <i>Stand no: 5181</i></b>
Manufacturing

Lonza appoints Hans Trees as Global Head of Communications

Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing

Cutting-edge wiped film evaporator installation – non-tobacco nicotine products

Successful system installation for a UK research and development facility developing and commercialising non-tobacco nicotine products using industry-leading evaporation equipment
Manufacturing

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Subscribe now